Abstract
The effect of acute or chronic administration of imipramine on fear-enhanced startle (potentiated startle) in rats was investigated. Thirty male albino rats were initially given preliminary startle testing, assigned to one of three matched groups, and trained for potentiated startle by presenting ten light-shock pairings on each of 2 days. Subsequent startle testing following a single injection of 0, 5 or 10 mg/kg imipramine revealed that the degree of startle potentiation (increased responding in the presence of the light previously paired with shock) was similar across treatment conditions. A significant and comparable potentiation of startle was observed in animals treated chronically with saline or imipramine (10 mg/kg/day) for 21 days between training and testing. Potentiated startle was also observed in these animals on the next (22 nd) day after injection of an additional dose of the drug (10 mg/kg) 5 min prior to testing. Plasma levels of imipramine and its metabolite, desipramine, were relatively high after each of these treatments. Since previous studies have shown that potentiated startle is decreased by diazepam, the present findings suggest that the potnetiated startle paradigm is a valid model for studying simple fear or anxiety rather than panic disorder.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berg WK, Davis M (1984) Diazepam blocks fear-enhanced startle elicited electrically from the brainstem. Physiol Behav 32:333–336
Brown JS, Kalish HI, Farber IE (1951) Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J Exp Psychol 41:317–328
Charney DS, Heninger GR, Sternberg DE (1982) Assessment of alpha-2 adrenergic autoreceptor function in humans: Effects of oral yohimbine. Life Sci 30:2033–2041
Chi CC (1965) The effect of amobarbital sodium on conditioned fear as measured by the potentiated startle response in rats. Psychopharmacologia 7:115–122
Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J (1981) Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Arch Pharmacol 317:209–213
Davis M (1979a) Diazepam and Flurazepam: Effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 62:1–7
Davis M (1979b) Morphine and naloxone: Effects on conditioned fear as measured with the potentiated startle paradigm. Eur J Pharmacol 54:341–347
Davis M, Redmond DE, Baraban JM (1979) Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology 65:111–118
Garfield SL, Gershon S, Sletten I, Sundland DM, Ballou S (1967) Chemically induced anxiety. Int J Neuropsychol 426–433
Hallstrom C, Treasaden I, Guy-Edwards J, Lader M (1981) Diazepam, propranolol and their combination in the management of chronic anxiety. Br J Psychiatry 139:417–421
Holmberg G, Gershon S (1961) Autonomic and psychic effect of yohimbine hydrochloride. Psychopharmacologia 2:93–106
Klein DF, Fink M (1962) Psychiatric reaction patterns to imipramine. Am J Psychiatry 119:432–438
Leonard BE, Kafoe WF (1976) A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain. Biochem Pharmacol 25:1939–1942
Mavissakalian M, Perel JM, Michelson L (1984) The relationship of plasma imipramine and N-desmethylimipramine to improvement in agorophobia. J Cl Psychopharmacology 4:36–40
McNair DM, Kahn RJ (1981) Imipramine compared with a benzodiazepine for agorophobia. In: Klein DF, Rabkin J (eds) Anxiety: New research and changing concepts. Raven Press, New York, pp 69–79
Nielsen M, Braestrup C (1977) Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain. Arch Pharmacol 300:87–92
Proelss HF, Lohmann HL, Miles DG (1978) High-performance liquid — chromatographic simultaneous determination of commonly used tricyclic antidepressants. Clin Chem 24:1948–1953
Sheehan DV (1982) Panic attacks and phobias. N Engl J Med 307:156–158
Sheehan DV, Ballenger J, Jacobsen G (1980) Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 37:51–59
Soffer A (1954) Regitine and benodaine in the diagnosis of pheochromocytoma. Med Clin North Am 38:375–384
Sugrue MF (1981) Current concepts on the mechanisms of action of antidepressant drugs. Pharmacol Ther 13:219–247
Sweeney DR, Gold MS, Pottash ALC, Martin D (1983) Plasma levels of tricyclic antidepressants in panic disorder. Int J Psychiatr Med 13:93–96
Tyrer PJ, Lader MH (1974) Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J 2:14–16
Van Wijk M, Meisch JJ, Korf J (1977) Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment. Psychopharmacology 55:217–223
Weiss GT, Davis M (1976) Automated system for acquisition and reduction of startle response data. Pharmacol Biochem Behav 4:713–720
Zitrin CM, Klein DF, Woerner MG, Ross DC (1983) Treatment of phobias I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125–138
Zitrin CM, Woerner MG, Klein DF (1981) Differentiation of panic anxiety from anticipatory anxiety and avoidance behavior. In: Klein DF, Rabkin J (eds) Anxiety: New research and changing concepts, Raven Press, New York, pp 27–46
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cassella, J.V., Davis, M. Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 87, 278–282 (1985). https://doi.org/10.1007/BF00432707
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432707